Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,34 USD | +0,75% | -1,47% | +8,06% |
Vakgebied
Aantal werknemers: 167
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 292 | 100,0 % | 195 | 100,0 % | -33,46% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 292 | 100,0 % | 195 | 100,0 % | -33,46% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Butler
CEO | Chief Executive Officer | 59 | 01-07-13 |
Tracey Vetterick
ADM | Chief Administrative Officer | - | 01-04-22 |
Michel Dahan
COO | Chief Operating Officer | 45 | 01-01-13 |
Steven Burke
CTO | Chief Tech/Sci/R&D Officer | 63 | 17-06-19 |
Chief Tech/Sci/R&D Officer | - | - | |
Corporate Officer/Principal | - | - | |
Carolyn Rucci
LAW | General Counsel | - | 01-01-21 |
Meredith Bowman
HRO | Human Resources Officer | - | 01-05-22 |
Christian Barnes
PRN | Corporate Officer/Principal | - | - |
Nicholas Grund
PRN | Corporate Officer/Principal | 54 | 09/01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Rogers
BRD | Director/Board Member | 64 | 12-12-18 |
Adrian Adams
CHM | Chairman | 73 | 12-12-18 |
Director/Board Member | 65 | 16-02-21 | |
John Butler
CEO | Chief Executive Officer | 59 | 01-07-13 |
Steven Gilman
BRD | Director/Board Member | 71 | 12-12-18 |
Ronald Frieson
BRD | Director/Board Member | 65 | 01-11-21 |
Cynthia Smith
BRD | Director/Board Member | 55 | 28-08-18 |
Myles Wolf
BRD | Director/Board Member | 53 | 06-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 209 595 254 | 188 221 008 ( 89,80 %) | 0 | 89,80 % |
Bedrijfsgegevens
Akebia Therapeutics, Inc.
245 First Street Suite 1400
02142, Cambridge
+617 871 2098
http://www.akebia.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,06% | 281 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers AKBA
- Onderneming Akebia Therapeutics, Inc.